血管緊張素Ⅱ受體1(AGTR1)重組蛋白
Recombinant Angiotensin II Receptor 1 (AGTR1)
AT1R; AG2S; AG2-S; AGTR1A; AGTR1B; AT1; AT1B; AT2R1; AT2-R1; AT2R1A; AT2R1B; HAT1R; AT1 Receptor; Angiotensin Receptor 1B
- 編號RPB658Hu03
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 來源原核表達(dá)
 - 宿主E.coli
 - 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
 - 亞細(xì)胞定位細(xì)胞膜
 - 預(yù)測分子量11.8kDa
 - 實(shí)際分子量13kDa(差異分析請參閱說明書)
 - 片段與標(biāo)簽Ile290~Glu359 with N-terminal His Tag
 - 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
 - 性狀凍干粉
 - 純度> 90%
 - 等電點(diǎn)10.2
 - 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價格¥ 1207¥ 3018¥ 6036¥ 18108¥ 45270
 - 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
序列

用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPB658Hu02 | 血管緊張素Ⅱ受體1(AGTR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPB658Hu03 | 血管緊張素Ⅱ受體1(AGTR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPB658Hu01 | 血管緊張素Ⅱ受體1(AGTR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAB658Hu01 | 血管緊張素Ⅱ受體1(AGTR1)多克隆抗體 | WB; IHC; ICC; IP. | 
| MAB658Hu22 | 血管緊張素Ⅱ受體1(AGTR1)單克隆抗體 | WB; IHC; ICC; IP. | 
| SEB658Hu | 血管緊張素Ⅱ受體1(AGTR1)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMB658Hu | 血管緊張素Ⅱ受體1(AGTR1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Journal of Atherosclerosis and Thrombosis | Involvement of Angiotensin II Type 1 and 2 Receptors in Gelatinase ReCavia (Guinea pig )lation in Human Carotid Atheroma in vitro[Pubmed:26947595] | 
| European Journal of Pharmaceutical Sciences | Vitamin D3 potentiates the renoprotective effects of vildagliptin in a rat model of fructose/salt-induced insulin resistance[Pubmed: 31866564] | 
| CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: Role of AMPK/SIRT1 activation and DPP-4 inhibition[Pubmed: 33108744] | 
| Fundam Clin Pharmacol | Vitamin D3 potentiates the nephroprotective effects of vildagliptin‐metformin combination in a rat model of metabolic syndrome[34453360] | 



